Cargando…
Anti-Acid Drug Treatment Induces Changes in the Gut Microbiome Composition of Hemodialysis Patients
Anti-acid drugs, proton pump inhibitor (PPI) and histamine-2 blocker (H(2)-blocker), are commonly prescribed to treat gastrointestinal disorders. These anti-acid drugs alter gut microbiota in the general population, but their effects are not known in hemodialysis patients. Hence, we investigated the...
Autores principales: | Lin, Yi-Ting, Lin, Ting-Yun, Hung, Szu-Chun, Liu, Po-Yu, Wu, Ping-Hsun, Chuang, Yun-Shiuan, Hung, Wei-Chun, Chiu, Yi-Wen, Kuo, Mei-Chuan, Wu, Chun-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910989/ https://www.ncbi.nlm.nih.gov/pubmed/33573326 http://dx.doi.org/10.3390/microorganisms9020286 |
Ejemplares similares
-
Differences in the Microbial Composition of Hemodialysis Patients Treated with and without β-Blockers
por: Lin, Yi-Ting, et al.
Publicado: (2021) -
Gut dysbiosis and mortality in hemodialysis patients
por: Lin, Ting-Yun, et al.
Publicado: (2021) -
Comparative Gut Microbiome Differences between Ferric Citrate and Calcium Carbonate Phosphate Binders in Patients with End-Stage Kidney Disease
por: Wu, Ping-Hsun, et al.
Publicado: (2020) -
Association between Circulation Indole-3-Acetic Acid Levels and Stem Cell Factor in Maintenance Hemodialysis Patients: A Cross-Sectional Study
por: Wu, Ping-Hsun, et al.
Publicado: (2020) -
High Cost and Low Survival Rate in High Comorbidity Incident Elderly Hemodialysis Patients
por: Lin, Yi-Ting, et al.
Publicado: (2013)